August 21, 2017

Finland to offer pioneering cancer treatment

According to Neutron Therapeutics, the high-quality of research at HYKS cancer centre and its previous experience with BNCT attracted it to launch the machine in Finland.
According to Neutron Therapeutics, the high-quality of research at HYKS cancer centre and its previous experience with BNCT attracted it to launch the machine in Finland.
Jarmo Nummenpää

Finnish hospital HYKS and American company Neutron Therapeutics are bringing a new cancer treatment to the international market.

The recently closed deal makes HYKSin cancer centre the first hospital in the world with a hospital-adapted BNCT machine. The BNCT radiotherapy is developed by Neutron Therapeutics and has proven successful in treaing cancer in the head and neck areas. The plan is to commence the treatment in Finland by autumn 2018.

The benefits of this new treatment is that all of the required radiotherapy can be given at once instead of the current methods where the patient receives radiotherapy multiple times. BNCT will also make it possible to focus the radiotherapy predominantly on the actual tumour, which will spare the healthy tissue.

“Being the first hospital in the world to offer BNCT treatments, HYKS cancer centre gets a significant advantage point on the international market for healthcare services,” says Johanna Mattson, the head of the cancer department at HYKS. “Our aim is also to clarify if BNCT treatments can be used for cancer in other body parts than the head and neck areas. This will further strengthen our position as a globally significant research and development centre for cancer treatments.”

Share: